Adipokine serum levels are related to liver histology in severely obese patients undergoing bariatric surgery.
BACKGROUND
Leptin, adiponectin, and resistin are adipokines linked to the development of insulin resistance, which plays a central role in the pathogenesis of nonalcoholic fatty liver disease (NAFLD). We aimed to define adipokine serum levels in severely obese patients undergoing bariatric surgery and to correlate these with anthropometric and metabolic variables, liver function tests, and histopathological parameters of NAFLD and nonalcoholic steatohepatitis (NASH).


METHODS
Surgical liver biopsies were obtained from 50 bariatric patients with no history of liver disease or significant alcohol consumption. Serum leptin, adiponectin, and resistin levels were measured, and histology was assessed using Brunt's and Kleiner's scoring systems.


RESULTS
Waist/hip ratio was significantly higher in men (p = 0.0001), and leptin (p = 0.036) and adiponectin (p = 0.0001) serum levels were higher in women. Forty-one of 50 patients (82%) had histological NAFLD, including 10 (20%) with NASH. Nine patients (18%) had normal liver histology (obese control subgroup). In NAFLD patients, serum adiponectin was negatively correlated with activity grade and fibrosis stage, resistin was negatively correlated with steatosis grade (p = 0.033), while leptin was not related to histology. Leptin/adiponectin ratio showed positive association with stage (p = 0.044). In the subgroup of NASH patients, adiponectin was negatively correlated only with stage (p = 0.01), while there was no correlation between leptin, resistin, or leptin/adiponectin and histology.


CONCLUSIONS
Serum adiponectin and resistin levels are related to liver histology in bariatric patients and may be indicative of the histological severity of NAFLD and the extent of hepatic steatosis, respectively. Serum leptin levels are not informative of underlying liver histology in severely obese patients.
Argentou
Marianna
M
Department of Surgery-Division of Nutritional Support and Morbid Obesity, Medical School, University of Patras, Patras, Greece.
Tiniakos
Dina G
DG
Karanikolas
Menelaos
M
Melachrinou
Maria
M
Makri
Maria G
MG
Kittas
Christos
C
Kalfarentzos
Fotis
F
D054392:Adipokines / Q000097:blood*; D000328:Adult; D015904:Biliopancreatic Diversion; D015992:Body Mass Index; D015331:Cohort Studies; D005234:Fatty Liver / Q000097:blood / Q000150:complications / Q000473:pathology*; D005260:Female; D006505:Hepatitis / Q000097:blood / Q000150:complications / Q000473:pathology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009767:Obesity, Morbid / Q000097:blood* / Q000150:complications* / Q000601:surgery; D012189:Retrospective Studies; D012307:Risk Factors; D055105:Waist Circumference
D054392:Adipokines
J Hepatol. 2008 May;48(5):829-34
18321606
Hepatology. 2005 Jun;41(6):1313-21
15915461
Expert Rev Mol Diagn. 2007 Mar;7(2):195-205
17331066
Am J Gastroenterol. 2007 Feb;102(2):399-408
17311652
Surg Endosc. 2007 Sep;21(9):1593-9
17294310
J Appl Physiol (1985). 1988 Feb;64(2):529-34
3372410
J Hepatol. 2008;48 Suppl 1:S104-12
18304679
Scand J Gastroenterol. 2008;43(9):1128-36
18609175
Hepatogastroenterology. 2007 Jul-Aug;54(77):1512-6
17708287
Hepatology. 2005 Nov;42(5):1175-83
16231364
Gastroenterology. 2008 May;134(6):1682-98
18471547
Diabetologia. 1985 Jul;28(7):412-9
3899825
J Pediatr Endocrinol Metab. 2004 Aug;17(8):1069-75
15379417
Hepatology. 2006 Feb;43(2 Suppl 1):S99-S112
16447287
Alcohol Clin Exp Res. 2007 Jan;31(1 Suppl):S15-21
17331160
Nutr Rev. 2007 Jun;65(6 Pt 2):S57-63
17605315
Obes Surg. 2005 Feb;15(2):228-37
15802066
Gastroenterology. 2006 May;130(6):1848-52
16697746
Mediators Inflamm. 2006;2006(6):34295
17392582
Med Clin North Am. 2007 Nov;91(6):1125-49, ix
17964913
J Hepatol. 2006 Oct;45(4):600-6
16899321
Curr Opin Clin Nutr Metab Care. 2008 May;11(3):267-74
18403923
Curr Opin Gastroenterol. 2007 Mar;23(2):193-8
17268250
J Clin Endocrinol Metab. 2004 Apr;89(4):1844-8
15070954
Hepatology. 2004 Jul;40(1):46-54
15239085
Am J Gastroenterol. 2006 Nov;101(11):2629-40
16952281
J Clin Endocrinol Metab. 2006 Mar;91(3):1081-6
16394091
Dig Dis Sci. 2008 Apr;53(4):1088-92
17934820
Clin Endocrinol (Oxf). 2006 Jun;64(6):679-83
16712671
Obes Surg. 2006 Oct;16(10):1351-8
17059746
Am J Gastroenterol. 2003 Dec;98(12):2771-6
14687831
Clin Chem. 1972 Jun;18(6):499-502
4337382
J Clin Endocrinol Metab. 2005 Jun;90(6):3498-504
15797948
Clin Liver Dis. 2007 Feb;11(1):191-207, x-xi
17544979
Gastroenterology. 2006 Sep;131(3):934-45
16952562
J Hepatol. 2004 Dec;41(6):943-9
15582127
Hepatology. 2005 Aug;42(2):490-2
15977205
Obes Surg. 2006 Dec;16(12):1584-93
17217634
Am J Gastroenterol. 2007 Sep;102(9):1931-8
17511754
Obes Surg. 2008 Nov;18(11):1430-7
18500507
Obes Surg. 2005 Mar;15(3):310-5
15826462
Hepatology. 2008 Feb;47(2):484-92
18220286
Scand J Gastroenterol. 2006 May;41(5):566-72
16638699
Am J Clin Pathol. 2007 Nov;128(5):837-47
17951208
Curr Opin Lipidol. 2006 Apr;17(2):170-5
16531754
Hepatology. 2007 Sep;46(3):716-22
17659597
J Clin Endocrinol Metab. 2006 Dec;91(12):5122-5
16968796
Eur J Endocrinol. 2005 Jan;152(1):113-8
15762194
Am J Gastroenterol. 1999 Sep;94(9):2467-74
10484010
Hepatology. 2007 Aug;46(2):582-9
17661414
Hepatology. 2003 May;37(5):1202-19
12717402
Obes Surg. 2000 Aug;10(4):378-9
11202981
Hepatology. 2002 Aug;36(2):403-9
12143049
JAMA. 2001 May 16;285(19):2486-97
11368702
Gut. 2005 Jan;54(1):117-21
15591515
Hepatology. 2003 Apr;37(4):917-23
12668987
Liver Int. 2006 Mar;26(2):151-6
16448452
Aliment Pharmacol Ther. 2008 Mar 1;27(5):412-21
18081738